Salute e Benessere

Oculis Publishes Notification of Major Changes in Voting Rights

Attachment Notification of Major Changes in Voting Rights - Brunnur
Nasdaq GlobeNewswire
04/01/2025

Genmab to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Media ReleaseCOPENHAGEN, Denmark; January 03, 2025 Genmab A/S (Nasdaq:GMAB)announced today that its CEO, Jan van de Winkel, Ph.D., will present a company update at the 43 rd Annual J.P. Morgan Healthcare Conference in San Francisco at 3:00 PMPST / 6:00 PM EST on January 14 , 2025 , 12:00 AM CET on January 15, 2025 . The live and archived webcast of the presentation will be available on Genmab's website at ...
Nasdaq GlobeNewswire
03/01/2025

CES 2025: JMGO Showcases the Future of Projectors with AI-Powered 'Bright, Even…

JMGO is showcasing three groundbreaking products, representing breakthroughs in triple laser technology, AI functionality, and industrial design: JMGO is showcasing three groundbreaking products, representing breakthroughs in triple laser technology, AI functionality, and industrial design: New Releases: Expanding the Google TV Lineup At CES 2025, JMGO is introducing its latest Q1 2025 Google TV products, the N1S4K, a Mini4KUHD triple laser projector launching online in March,...
PR Newswire
03/01/2025

VALNEVA Declaration of shares and voting rights: December 31, 2024

VALNEVADeclaration of shares and voting rightsDecember 31, 2024__________________________________________________________________________________________Company name: VALNEVA Registered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France) Regulated market of Euronext Paris - Compartment B Declaration date: January 3, 2025 Number of sharescomposing the share capital of ValnevaTotal number of voting rights including suspended voting rights* Description of the...
Nasdaq GlobeNewswire
03/01/2025

Cell Therapy and Gene Therapy CDMO Market to Reach USD 11.11 Billion by 2030 |…

Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-4J16455/Global_Cell_Therapy_and_Gene_Therapy_CDMO_Market Get Free Sample:https://reports.valuates.com/request/sample/QYRE-Auto-4J16455/Global_Cell_Therapy_and_Gene_Therapy_CDMO_Market Major Factors Driving the Growth of Cell Therapy and Gene Therapy CDMO Market: The Cell Therapy and Gene Therapy CDMO market is poised for substantial growth, driven by the increasing demand for innovative and personalized...
PR Newswire
03/01/2025

AccuStem Sciences, Inc. Announces Chairman Purchase of Shares

LONDON and PHOENIX, Jan.03, 2025(GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced that its Chairman of the Board, Mr. Gabriele Cerrone, has notified the Company that he has recently purchased an additional 100,000 ACUT shares in the open market. This brings his total holding to 4,719,957 shares. About AccuStem AccuStem is a clinical stage diagnostics company dedicated to...
Nasdaq GlobeNewswire
03/01/2025

Trading by management and close relations of management

In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of Novonesis Group reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B. The released shares relate to the 2022 legacy Chr. Hansen restricted stock units (RSU) program.Please see the full announcement in pdf. Attachment...
Nasdaq GlobeNewswire
03/01/2025

The Or Foundation Commits $1 Million USD to Kantamanto Market Emergency Relief…

15 million secondhand garments arrive from the Global North in Kantamanto Market every week, and the community of more than 30,000 people working in Kantamanto Market is responsible for recirculating 25 million pieces of secondhand clothing every month through resale, reuse, repair, and remanufacturing. It's a vibrant hub of creativity and a necessary alternative to fast fashion. The fire, which occurred on January 1, has left many families in distress following catastrophic losses for…
PR Newswire
03/01/2025

The Mayo Clinic, the leading US hospital, will test Nevisense in Pilot

"We are proud to work with the Mayo Clinic and believe this pilot represents an opportunity for SciBase to continue to address an unmet medical need by expanding access of the Nevisense test to more US patients at-point-of-care, when it is critical and makes a profound impact on patient care," said Pia Renaudin, CEO of SciBase. "We are proud to work with the Mayo Clinic and believe this pilot represents an opportunity for SciBase to continue to address an unmet medical need by…
PR Newswire
03/01/2025

Optimizing Outsourcing: A Case Study on Evaluating CDMO Capabilities for API and…

The global Contract Development and Manufacturing Organization market is set to experience significant growth, driven by its essential role in outsourcing drug development and manufacturing for pharmaceutical companies. According to the latest report by DelveInsight's recent Contract Development Manufacturing Organization (CDMO) forecast report, the CDMO market was valued at USD 100.02 billion in 2021 and is projected to grow at a CAGR of 6.25%, reaching USD 143.87 billion by 2030. The global...
PR Newswire
02/01/2025

Alkermes to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Alkermes Contact: Jamie ConstantineInvestor Relations+1 781 873 2402 Alkermes Contact: Jamie ConstantineInvestor Relations +1 781 873 2402 View original content: https://www.prnewswire.co.uk/news-releases/alkermes-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-302341500.html
PR Newswire
02/01/2025

CathWorks Announces the Completion of Enrollment for Landmark ALL-RISE…

The ALL-RISE Study included over 1,924 patients across 59 sites in North America, Asia, Europe and the Middle East. Participants presenting with coronary stenoses of intermediate significance and requiring physiology assessment were randomized to receive either FFRangio-guided treatment or invasive pressure wire-guided treatment. Notably, this was the first-ever randomized controlled trial in the United States to assess clinical outcomes using an angiography-based tool for physiologic lesion…
PR Newswire
02/01/2025

EssilorLuxottica strengthens its presence in the hearing space with the…

EssilorLuxottica strengthens its presence in the hearing space with the acquisition of an AI-driven tech startup in France Pulse Audition features technology that can embed AI-based speech enhancement into glasses Paris, France (2 January 2025)– EssilorLuxottica takes a leap forward in its innovation journey with the acquisition of Pulse Audition, a French startup delivering AI-based noise reduction and voice enhancement through algorithms allowing people with hearing impairment to...
Nasdaq GlobeNewswire
02/01/2025

Automatic Blister Packaging Machine Market to Reach USD 985.5 Million by 2030 -…

Claim Your Free Report: https://reports.valuates.com/request/sample/QYRE-Auto-31D8008/Global_Automatic_Blister_Packaging_Machine_Market Claim Your Free Report:https://reports.valuates.com/request/sample/QYRE-Auto-31D8008/Global_Automatic_Blister_Packaging_Machine_Market Major Factors Driving the Growth of Automatic Blister Packaging Machine Market: The Automatic Blister Packaging Machine market is poised for significant growth, driven by the increasing demand for efficient and...
PR Newswire
02/01/2025

Exploring Opportunities in the Nutritional Supplements Market: Projected Growth…

IMR
02/01/2025

Veeda Group Rebrands as 'Veeda Lifesciences'

Dr. Mahesh Bhalgat, Group CEO and Managing Director of Veeda Lifesciences, stated, "The name – Veeda Lifesciences – and the new logo, designed to be modern and dynamic, symbolize the Group's forward-thinking approach and dedication to its core values and mission. It adds aspirational value to our growth and vision for the future, striving for innovation, excellence, and client satisfaction. We continue to diversify our base offering services serving the growing needs of our clients."…
PR Newswire
02/01/2025

The exercise period for warrants of series TO 2 beings today: Immunovia AB

Please note that warrants of series TO 2 that are not exercised by 16 January 2025, or sold by 14 January 2025, expire worthless. In order for the warrants not to expire, active subscription of shares or sale of warrants is required. Please note that some nominees may close their application earlier than 16 January 2025. Please note that warrants of series TO 2 that are not exercised by16 January 2025, or sold by14 January 2025, expire worthless. In order for the warrants not to expire,...
PR Newswire
02/01/2025

Poolbeg Pharma plc (“Poolbeg” or the “Company”) Combination of Poolbeg and…

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.4 OF THE CITY CODE ON TAKEOVERS AND MERGERS (“THE CODE”) AND DOES NOT CONSTITUTE AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CODE. THERE CAN BE NO CERTAINTY THAT AN OFFER WILL BE MADE.THIS ANNOUNCEMENT...
Nasdaq GlobeNewswire
02/01/2025

Revolutionizing Surgical Precision: Genesis Medtech's World's First 90°…

The iReach Omnia sets a new standard in surgical stapling with its 90° articulation capability, providing surgeons with the maneuverability and precision necessary to perform effective stapling even in the most confined spaces. This innovation potentially reduces the need for multiple stapler firings, minimizes weak points in the staple line, thus lowering the risk of anastomotic leakage. By addressing these critical issues, the iReach Omnia empowers surgeons to deliver better patient outcomes…
PR Newswire
02/01/2025

CES 2025: Aurafit to Unveil G12 Smartwatch, the Ultimate Companion for A…

AI functionalities are at the core of the G12 Smartwatch, offering an AI voice assistant, AI voice-activated watch faces, AI smart translation, AI voice notes, and AI art watch faces. These features transform the smartwatch into a powerful tool for managing daily tasks, staying connected, and expressing creativity. Whether setting reminders, taking notes, or translating languages on the go, the G12 Smartwatch enhances efficiency and organization in daily life. AI functionalities are at the…
PR Newswire
01/01/2025

Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of…

Each Unit is comprised of one common share of the Company (a " Common Share ") and one common share purchase warrant of the Company (a " Warrant "). Each Warrant will entitle the holder thereof to purchase one Common Share at an exercise price ofC$0.28for a period of four (4) years from the date of issuance. The Company paid an arm's length finder a cash fee ofC$13,500and issued to the finder 67,500 warrants attributable to investors introduced to the Company by the...
PR Newswire
31/12/2024

Unlock Radiant Skin with DermRays Revive Laser Beauty Device - The Ultimate New…

Why Laser Devices Lead the Way in Skincare Technology Why Laser Devices Lead the Way in Skincare Technology While RF, EMS, and LED devices have their benefits,Laser treatmentsare renowned for their precision and deep skin penetration. DermRays Revive Laser Beauty Device uses targeted light energy to stimulate collagen production and address skin concerns such as fine lines, wrinkles, uneven tone, and texture. Unlike RF or EMS, which primarily work on tightening and toning the...
PR Newswire
31/12/2024

NOBLE Registry Update: TLX599-CDx PSMA SPECT Imaging of Prostate Cancer…

SPECT cameras are being clinically evaluated in this application because they are more widely available than the PET/CT[3] scanners used for gallium- or fluorine-based PSMA imaging, where access can be limited by socio-economic or geographic factors, as well as healthcare funding models. For every PET scanner available globally, there are four SPECT machines[4], making them a more accessible option when used with 99mTc – a radionuclide with a well-established supply chain, which can be produced…
PR Newswire
30/12/2024

Artificial Intelligence (AI) in Cancer Market to Grow at a CAGR of 23.1%

The report explores AI technology's current and future potential in cancer applications, considering market drivers, restraints, and opportunities. It includes projections through 2029 and examines the competitive landscape. In this report, the market is segmented by application (screening, diagnosis, therapy, drug discovery, etc.), cancer type (breast, lung, prostate, etc.), and end-user (hospitals, diagnostic centers, etc.). It covers the regions of North America, Europe, Asia Pacific, and the…
PR Newswire
30/12/2024
Altri  Comunicati